Exclusive news, features, and analysis on the research, tools, regulations, and applications driving precision medicine. From the publisher of @GENBio

Joined April 2014
12,241 Photos and videos
Pinned Tweet
🎧 Behind the Breakthroughs Step into the minds shaping the future of medicine. Listen on your preferred platform: Apple → hubs.li/Q03CQZRK0 Spotify → hubs.li/Q03CQYNy0 IPM → hubs.li/Q03CQYph0 #PrecisionMedicine #BehindTheBreakthroughs #MedTech #Biotech
1
7
11
1,224
Inside Precision Medicine retweeted
“I want people to see the massive ways that we could treat cancer,” Prof. Neil Forbes tells Inside @Inside_PM about a UMass study that highlights a new approach to fighting cancer. “There are a lot of possibilities that I think are untapped.” bit.ly/4olmZVT
3
11
829
Lipid-Protein Biomarker Makes Clinical Debut with Early Ovarian Cancer Detection @AOA_Dx combined AI with multi-omic ovarian cancer biomarkers to make the first ovarian cancer diagnostic breakthrough in 35 years #AI #ovariancancer #biomarkers hubs.li/Q04lfrG60
65
Unlock strategies to reduce drug development risk by downloading our free eBook, “Protein Biomarkers in Practice,” featuring insights from top pharma leaders. Sponsored by Olink: hubs.ly/Q04fZPRt0 #ProteinBiomarker #DrugDevelopment #Proteomics
1
2
58
Signatera™ as a Pan-Cancer Decision-Making Tool to Illuminate the Care Pathway Signatera ctDNA testing bridges the gap from uncertainty to actionability by answering meaningful questions at each stage of the patient’s journey. Sponsored: @NateraGenetics hubs.li/Q04kN72X0
3
2
163
Discover cutting-edge NGS in myeloid malignancy testing with insights from a leading Portuguese center. Join our free webinar on June 30, sponsored by @SOPHiAGENETICS. Register: hubs.li/Q04jXGkl0 #NGS #CancerTesting
83
GLP-1 Drugs Linked to Lower Rates of Substance Use Disorders GLP-1 RA medications may influence dopamine signaling and other neural pathways that drive cravings not just for food but other substances @UTEP #GLP1 #substanceusedisorder #obesity hubs.li/Q04kJD390
77
Microglial State Shift May Determine Whether Alzheimer’s Disease Pathology Leads to Dementia A microglial transition in AD may influence whether the accumulation of amyloid-β plaques and tau pathology progresses to #dementia @UKDRI @muna_tx #Alzheimers hubs.li/Q04ks6yf0
5
7
246